洛克菲勒大学研究人员在《Cell》期刊发表最新成果,揭示常见氨基酸“精氨酸”在维持免疫系统识别癌细胞和病毒方面发挥关键作用 1。该研究于2026年11月15日发表,主要作者包括通讯作者Sohail Tavazoie及第一作者Qiushuang Wu 1。实验数据显示,低精氨酸饮食会导致小鼠结肠癌肿瘤数量增加,而在感染发生后补充精氨酸仍有助于减轻流感及SARS-CoV-2感染的症状并促进恢复 1。
从机制层面来看,精氨酸缺乏会阻碍核糖体合成MHC-1蛋白,进而导致T细胞无法有效识别异常细胞,使危险细胞逃脱免疫监测 1。对此,第一作者Qiushuang Wu指出:“我们的研究揭示了精氨酸缺乏如何干扰免疫系统,并表明增加精氨酸摄入量可能是有益的。” 1 尽管人类临床验证尚需时日,但通讯作者Sohail Tavazoie表示,鉴于精氨酸价格低廉且易于获取,团队希望能尽快开展相关的治疗性和预防性研究 1。这一发现为通过廉价营养补充剂辅助癌症免疫治疗及预防病毒感染提供了新的科学依据 1。
Researchers at Rockefeller University have identified the common amino acid arginine as a critical factor in maintaining the immune system’s ability to detect cancer cells and viral infections. Published in the journal Cell on November 15, 2026, the study reveals that a lack of arginine hinders ribosomes from synthesizing MHC-1 proteins, effectively allowing dangerous cells to escape surveillance by T-cells 1. The findings suggest that adequate arginine levels are essential for the immune system to properly identify and target abnormal cells within the body 1.
In mouse models, dietary restriction of arginine resulted in an increased number of colon cancer tumors, highlighting the link between nutrient availability and disease progression 1. Conversely, supplementing with arginine significantly reduced tumor burden and improved outcomes for mice infected with influenza and SARS-CoV-2 1. Notably, the researchers discovered that administering arginine after infection had already occurred still aided in recovery, indicating potential therapeutic benefits even in established cases 1. Qiushuang Wu, the study’s first author, stated that their research "revealed how arginine deficiency interferes with the immune system and suggested that increasing arginine intake may be beneficial" 1.
While clinical validation in humans remains necessary, the team sees promising implications for using inexpensive nutritional supplements to support cancer immunotherapy and prevent viral infections. Sohail Tavazoie, the corresponding author, emphasized the accessibility of this intervention, noting, "Considering that arginine is cheap and readily available, we hope to conduct therapeutic and preventive studies as soon as possible" 1. The full details of the research were published in Cell (2026; 189 (19): 6012), providing a scientific basis for future trials exploring arginine supplementation as a public health strategy 1.
评论
还没有评论,欢迎留下第一条。